Adrenal Tumor Clinical Trial
Official title:
Impact of Adrenal IncidenTalomas and Possible Autonomous Cortisol Secretion on Cardiovascular and Metabolic Alterations (ITACA Study)
The investigators hypothesize that cardiovascular and metabolic alterations can occur in patients with adrenal adenomas and possible Autonomous Cortisol Secretion (pACS). Investigators hypothesize that adrenalectomy in selected patients, following the 2016 ECE guidelines, can improve metabolic parameters and cardiovascular risks and features.
Adrenal incidentalomas are clinically silent masses discovered inadvertently during diagnostic imaging procedures performed for unrelated reasons. Depending on the criteria applied, up to 50% of patients with adrenal incidentalomas may have biochemical evidence of cortisol excess. Possible autonomous cortisol secretion (pACS), as defined in the 2016 European Society of Endocrinology Guidelines, is characterized by a partial, incomplete suppression of the hypothalamic-pituitary-adrenal (HPA) axis without the typical signs of overt cortisol hypersecretion. Investigators will perform a prospective longitudinal study in patients with adrenal incidentalomas associated with possible autonomous cortisol secretion, aiming to assess the effect of surgical and conservative management on cardiovascular and metabolic features. Data will be detected at baseline, at 1 and at 5 years follow-up to quantitatively identify the different cardiovascular and metabolic alterations in: (1) patients with non-functioning adrenal adenoma; (2) patients with possible autonomous cortisol secretion receiving conservative management; (3) patients with possible autonomous cortisol secretion receiving adrenalectomy according to the 2016 European Society of Endocrinology guidelines; (4) patients without adrenal masses. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06050057 -
Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy
|
||
| Completed |
NCT06330558 -
Side-specific Factors for Conversion in Adrenalectomy for Pheochromocytoma.
|
||
| Completed |
NCT04071561 -
Prevention of Conversion in Posterior Retroperitoneal Adrenalectomy by Measuring Preoperative Anatomical Conditions
|
||
| Recruiting |
NCT06229405 -
Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data
|
||
| Completed |
NCT00454103 -
Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy
|
Phase 1/Phase 2 | |
| Completed |
NCT03469102 -
18FDG PET Textural Indices in Adrenal Lesion
|
||
| Completed |
NCT01959711 -
Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenalectomy
|
Phase 4 | |
| Recruiting |
NCT04905706 -
3D Laparoscopic Adrenalectomies for Adrenal Tumors
|
||
| Completed |
NCT03830593 -
Laparoscopic Adrenalectomy for Large Adrenal Tumors.
|
||
| Recruiting |
NCT05739812 -
The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery
|
N/A | |
| Completed |
NCT03739918 -
Rare Cystic Benign Adrenal Incidentalomas
|
||
| Completed |
NCT04804163 -
Research on the Effectiveness and Safety of Remote Control of Domestic Surgical Robot System for Urinary Surgery
|
Early Phase 1 | |
| Completed |
NCT03327142 -
EUS-guided FNA in the Study of the Adrenal Gland
|
N/A | |
| Completed |
NCT04570176 -
Efficacy and Safety of Clinical Telesurgery Using Chinese Independently Developed Surgical Robot System
|
N/A | |
| Not yet recruiting |
NCT04432532 -
Neuroendocrine and Adrenal Tumors
|